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This issue’s Molecular Biology Select highlights recent studies that reveal diverse roles for RNA in an array of cellular pro-
cesses. Two studies report the trans-splicing of mRNA transcripts to create chimeric gene products. Three other reports
uncover roles for RNA in limiting the pausing of polymerase during transcription and mediating pathogen defense in
plants and prokaryotes.
An RNAi Regulator Cut from Different Strands
The process of mRNA splicing usually occurs in cis, that is, between exons
present within a single transcript. A new report from Fischer et al. (2008) now
describes an exciting example of splicing of exons from two separate mRNAs
(trans-splicing) in the nematode Caenorhabditis elegans. The authors identified
two adjacent genes, eri-6 and eri-7, in a genetic screen seeking to uncover
negative regulators of RNA interference (RNAi). Both genes show overlapping
expression patterns in the worm. Although eri-6 and eri-7 are divergently
transcribed from the chromosome, their transcripts are assembled into a single
mRNA encoding a member of the DNA and RNA helicase superfamily I.
Messenger RNA transcripts derived only from eri-6 or eri-7 were not detected
in the worm, nor were genomic rearrangements that may explain the origin of
the chimeric RNA. Identification of canonical cis-splicing sites at the trans-
splicing juncture in the eri-6/-7 message further supported the notion that the
two mRNAs are trans-spliced. Fischer and colleagues propose that two direct
repeats flanking eri-6, one of which could also be a part of the eri-7 50 UTR,
mediate trans-splicing by allowing the two RNAs to base pair with one another.
Indeed, the 30 direct repeat that is likely to be part of the eri-6 30UTR is required
to fully complement the mutant phenotype in worms lacking eri-7. Furthermore,
evidence of RNA editing in the repeat region of the eri-7 50UTR by an adenosine
deaminase suggests the formation of an RNA duplex intermediate during
trans-splicing. Intriguingly, the Eri-6/-7 protein seems to play a role in both endogenous and exogenous RNAi pathways, negatively regulating
the response to exogenous double-stranded RNA and promoting production of certain endogenous siRNAs.
S.E. Fischer et al. (2008). Nature. Published online September 10, 2008. 10.1038/nature07274.
Gene Fusion Jazzed Up by trans-Splicing
About 50% of human endometrial stromal sarcomas harbor a chromosomal translocation that gives rise to fusion of the genes JAZF1 and
JJAZ1/SUZ12. This chimeric gene encodes a protein that confers resistance to apoptosis in cultured cells. In a new study, Li et al. (2008)
make the startling discovery that in normal human endometrial cells, the JAZF1 and JJAZ1/SUZ12 transcripts are trans-spliced to encode
a gene product identical to that produced by gene fusion in sarcomas. In normal cells, JAZF1 and JJAZ1 are located on two separate chro-
mosomes. Yet the authors observed the presence of JAZF1-JJAZ1 fusion transcripts encompassing the first three exons of JAZF1 fused to
the last 15 exons of JJAZ1 in human endometrial stromal cell (HESC) lines and in normal human uterine tissue. After analysis of genomic DNA
fromHESCs confirmed that these cells harbor no chromosomal translocations ormore subtle rearrangements involving the two genes, Li et al.
sought to determine whether the chimeric RNA is the result of trans-splicing. The authorsmade use of a primary rhesus fibroblast (RF) cell line
that expressed a JAZF1 gene differing from theHESC JAZF1 by two nucleotides.When the authorsmixedHESCnuclear extractswith purified
RNA fromRF cells, theywere able to detect chimeric RNAs of RF JAZF1 andHESC JJAZ1 harboring the same trans-spliced junction. Notably,
the authors uncovered evidence for regulation of this trans-splicing event. JAZF1-JJAZ1RNAswere only detected in endometrial tissue of the
uterus and seemed to fluctuatewith specific phases of themenstrual cycle. Indeed, trans-splicedRNAswere not detectable in HESCs treated
with high levels of steroid hormones. Intriguingly, when HESCs were treated with desferroximine to mimic the hypoxic conditions of the en-
dometrium during the late secretory phase of the menstrual cycle, the amount of JAZF1-JJAZ1 RNA increased without an increase in JAZF1
or JJAZ1mRNA levels. A possible link between this trans-spliced gene product and the acquisition of its gene fusion doppelganger in tumors
remains to be elucidated.
H. Li et al. (2008). Science 321, 1357–1361.
RNA Hits the Resume Button
During transcript elongation, RNA polymerase can be induced to pause for varying amounts of time as a way to regulate gene expression.
During transcription of bacteriophage HK022, the RNA polymerase pauses at a U-rich sequence region downstream of putL, a site encoding
an RNA stem loop structure that prevents transcription termination. Komissarova et al. (2008) now report a role for the putL RNA in regulating
RNA polymerase pausing. Mutants of putL RNA defective in preventing termination increased the efficiency of the U-rich pause site in induc-
ing pausing in vitro. Importantly, some of the putL mutants preserved stem-loop formation. Examination of the structure of the elongation
complex at the pause site revealed that pausing is accomplished by polymerase backtracking along the DNA template. This process requires
Instead of being only cis-spliced during RNA processing,
eri-6 and eri-7 pre-mRNAs are trans-spliced together to
form the eri-6/-7 mRNA that encodes an RNAi regulator.
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breakage of the RNA-DNA hybrid at the growing 30 end of the nascent transcript and recession of the up-
stream RNA and DNA back into the polymerase. Remarkably, putL RNA suppression of pausing occurs in
a distance-dependent manner (unlike its anti-termination function). Increasing the distance in the DNA
between the pause site and the putL site by only a few base pairs abrogated the ability of putLRNA to inhibit
polymerase pausing. Given the known physical interaction between putLRNA and the elongation complex,
Komissarova and colleagues propose an intriguing model in which pause inhibition is mediated by binding
of the nascent putL RNA to the polymerase near the RNA exit channel, thus blocking reentry of the
transcript, which is necessary for polymerase backtracking during pausing. Thismodel allowed an estimate
of the location of the putL-binding site on the surface of polymerase that was consistent with the genetic
data, thus supporting the notion that physical blockage of polymerase backtracking is the mechanism
underlying the RNA-mediated inhibition of pausing observed in this study.
N. Komissarova et al. (2008). Mol. Cell 31, 683–694.
MicroRNAs, Now for Defense against Bacteria Too!
RNA silencing has long been appreciated as an antiviral defense mechanism.
Navarro et al. (2008) now show that the miRNA pathway also plays a major
role in plant basal defense against bacterial pathogens. The authors find that,
like viruses, bacteria have evolved to suppress different steps of the miRNA
pathway. As in animals, plants challenged by bacterial pathogens sense path-
ogen-associatedmolecular patterns (PAMPs) that activate PAMP-triggered im-
munity (PTI). To determine the contribution to PTI by the miRNA pathway, the
authors first asked whether Arabidopsis thaliana plants unable to accumulate
miRNAs were more susceptible to nonvirulent Pseudomonas syringae. This
bacteria is unable to repress PTI and grows poorly on wild-type plants. How-
ever, it grew successfully on leaves of Arabidopsismutants deficient in miRNA
accumulation or on wild-type leaves preinfected with a virus that suppresses
siRNA/miRNA functions. These findings suggest a requirement for miRNAs in
PTI. Furthermore, themiRNApathway also plays a role in immunity against gen-
eral bacterial challenge (nonhost resistance), a process to which PTI is a major
contributor. Leaves of Arabidopsis defective in miRNA accumulation were permissive for growth of nonpathogenic bacteria. Navarro and col-
leagues identified the PAMP-associated miRNAs mi393a and mi393b as targets of effector proteins from pathogenic Pseudomonas. They
further implicated these bacterial effectors in the suppression of PAMP-triggered induction of miRNAs, as well as in miRNA biogenesis
and activity. Beyond broadening the role of miRNAs in plant innate immunity, this study raises an interesting question—could similar inhibitory
mechanisms be used by human bacterial pathogens?
L. Navarro et al. (2008). Science 321, 964–967.
CRISPR Insights into Prokaryotic Antiviral Defense
To defend against viral infection, many bacteria and archaea use a system of clustered regularly interspaced short palindromic repeats
(CRISPRs) where viral DNA sequences (spacers) are incorporated within the genomic CRISPR locus to confer immunity. Although the exact
mechanisms remain unclear, Brouns et al. (2008) now providemolecular details that give insights into how these CRISPR sequences are used
to mount a defense against invading viruses. Using affinity purification from the bacterium Escherichia coli, the authors identified a protein
complex (Cascade, CRISPR-associated complex for antiviral defense) composed of five proteins encoded by CRISPR-associated (cas)
genes that lie upstreamof theCRISPR locus in theE. coli genome. Loss of any of these five cas genes (casA–E) inE. coli altered the processing
of a small 57 nucleotide CRISPR RNA (crRNA) from a larger precursor RNA (pre-crRNA). In vitro cleavage assays demonstrated that the
CasE subunit provided the bacterial strain-specific pre-crRNA cleavage activity of Cascade. Sequencing of crRNAs revealed that each
RNA consists of an individual spacer from the CRISPR locus, suggesting an RNA-mediated mechanism for limiting viral replication during
infection. crRNA sequences further revealed that cleavage sites in the pre-crRNA are located in the repeat regions in the CRISPR locus, which
are thought to form stem-loop structures recognized by Cascade subunits. Consistent with a crucial role for crRNAs in viral defense, the au-
thors found that in E. coli engineered with artificial CRISPRs against the bacteriophage lambda, loss of Cascade cleavage activity in vivo
through mutation of CasE abrogated lambda resistance. As crRNAs remain associated with Cascade following cleavage, Brouns et al. pro-
pose that following Cascade-directed maturation, crRNAs function in the specific targeting of Cascade to viral nucleic acids. Surprisingly,
Brouns et al. observed that although Cascade is necessary for resistance against lambda in the engineered E. coli strain, it is not sufficient
to limit viral infection. Indeed, Cas3, another cas protein with putative nuclease and helicase activity, is also required. The exact roles played
by Cas3 and other Cascade components in CRISPR-mediated antiviral defense remain an exciting area for future study.
S.J.J. Brouns et al. (2008). Science 321, 960–963.
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